Our collective members present themselves:
Spiez Laboratory is the Swiss Institute for NBC-Protection. It deals with the scientific and technical aspects of hazards associated with NBC incidents.
It has the requisite laboratories and measuring equipment to ensure that it can fullfil this task. In addition, Spiez Laboratory uses its technical expertise to support Switzerland’s arms control and peacekeeping efforts.
More information is avaiable at www.labor-spiez.ch.
Our commitment to saving lives and improving the quality of life for people with serious and rare conditions is evident in everything we do. Whether we are manufacturing and marketing safe and effective products or researching and developing innovative biotherapies, we are first and foremost focused on fulfilling our customers’ needs.
For additional information please visit www.cslbehring.ch.
Institute of Virology and Immunology (IVI)
The Institute of Virology and Immunology at the Mittelhäusern site is the Swiss reference laboratory for the diagnosis, surveillance and control of highly infectious animal diseases such as fowl pest (avian influenza), foot and mouth disease and classical swine fever. The IVI investigates the emergence of new diseases in animals and their potential for transmission to humans. It is the approval authority for vaccines and sera for animals. The IVI is part of the Federal Food Safety and Veterinary Office (FSVO).
More information is available under www.bvet.admin.ch/ivi.
Department Clinical Research DCR
The mission of the Department Clinical Research DCR is to provide the researchers of the Inselspital (Bern University hospital, www.insel.ch) with the best possible environment and infrastructures. As you will see by browsing through our website, 47 independent research groups of the Inselspital and Faculty of Medicine, covering almost all fields of biomedical research, are affiliated to the DCR. Our aim is to bridge laboratory-based research with patient-oriented clinical research, by providing state-of-the-art core facilities to the researchers. It also hosts the Clinical Trials Unit (CTU) Bern.
On the homepage www.dkf.unibe.ch you’ll find information regarding research activities within the DCR.
Institute of Anatomy
The Institute of Anatomy belongs to the medical faculty of the University of Bern. Its scope of duties comprise preclinical teaching in human, dentist and veterinary medical curricula as well as in many other paramedical fields. Research topics include base science in the fields of skeletal and smooth muscle, the lung and its development, particle interactions in the lung, stereology and others.
The institute is subdivided into the “Division of cell biology”, the “Division of systematic and functional anatomy” and the “Division of topographical and clinical anatomy” The institute has about 60 persons staff.
On the website www.ana.unibe.ch you’ll find more about the research activities of the Institute of Anatomy.
Department of Physiology
Physiology is the science of the processes governing life. It describes the physical, biochemical and information processing functions of living systems at the level of the entire organism, the organs and the cells. The Department of Physiology provides under-graduate and post-graduate education for medical- and life-science students. It carries out research mainly in the field of heart- and neurophysiology.
Find out more under www.physio.unibe.ch
Department of Medicine
The Department of Medicine is one of the seven Departments of the Faculty of Sciences the University of Fribourg. It hosts 13 full professors and 7 associate professors. The Department of Medicine of the Faculty of Sciences is devoted to teaching and research in the field of Medicine, Biomedical Sciences, Sport and Movement Sciences and Pharmacy. It is currently experiencing a very exciting momentum of transition and development with profound impact on research activities.
Please find more information about the Department of Medicine on their website: www.unifr.ch/med
The InnoMedica In addition to a patented technology, InnoMedica is defined especially by the will of a team to develop out of an innovative research in the field of liposomal targeting a pharmaceutical drug and to bring this therapy to the patients. To achieve this goal, experienced entrepreneurs and managers work alongside young university graduates. In addition, we are also supported by a variety of people outside the company. Only the combined efforts of investors, employees, physicians and patients will eventually make it possible to go the long way to register a prescription drug.
Please find more information about InnoMedica on their website: http://www.innomedica.com/